Roche China CEO preps for a move to Merck KGaA while US Merck adds to C-suite; Succession plan finalized for EVPs retiring from Sanofi

Hong Chow

→ Beginning Oct. 1, Roche China CEO Hong Chow will be head of China & international for Merck KGaA’s healthcare business, a position that also encompasses Japan, Europe, Latin America, Asia-Pacific, the Middle East, Africa and Russia. The multi-pronged position...

Click to view original post